Founded in 2011, EMGI is a dynamic and steadily growing company, specialized in the import and distribution of pharmaceutical, nutraceutical, and cosmetic raw materials sourced from carefully selected manufacturers. We operate with the goal of providing our partners with quality, safety, and reliability, ensuring full compliance with GMP and GDP regulations at every stage of the supply chain.
Thanks to a team with solid experience in the sector and an international network of qualified suppliers, we support our clients throughout the entire process — from identifying the most suitable active substance, to logistics management, up to final delivery.
Our activity goes beyond mere distribution: EMGI acts as a technical and strategic partner, capable of developing customized projects tailored to clients’ specific needs, ensuring expertise, flexibility, and constant updates on market developments.
With a continuously expanding product portfolio, reflecting our commitment to innovation and technical advancement, and a collaborative approach, we work every day to build long-lasting partnerships based on trust and quality results.
Mission
To provide high-quality raw materials and reliable services for the pharmaceutical, nutraceutical, and cosmetic sectors, ensuring full regulatory compliance and continuous technical support.
Our goal is to act as a trusted partner for our clients, offering customized solutions that contribute to the growth and success of their projects.
Vision
To be recognized as a benchmark in the European market for the import and distribution of high-quality raw materials, distinguished by expertise, integrity, and innovation.
We aim to promote a safer, more transparent, and sustainable supply chain, where quality becomes a shared value among us, our partners, and our end clients.
Importation
We boast a fast import strategy that enables our clients to receive their desired active ingredient in Europe faster than any other provider.
Collaborations
We collaborate with leading multinational pharmaceutical companies and serve as a strategic partner for the most important active ingredient manufacturers in Europe, China, and India.
2011
founded on the two decades of prior experience of its management team and a well-established network of partners.
2018
cGMP certification and import authorization from AIFA
2019
Authorization for the import of sterile and biologically derived products
2019
Establishment of Alikon srl, a new start-up focused on the development of registration dossiers for medicinal specialties
2022
Industria Felix Award: Competitive, Reliable and Sustainable Companies
2025
Authorization from the Ministry of Health for the import of active ingredients used as starting materials for veterinary medicines
2025
Impresa Champion 2025 Award by Italypost
